China Universal Asset Management Co., Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 69,527 shares of LXRX stock, worth $52,840. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,527
Previous 42,469
63.71%
Holding current value
$52,840
Previous $71,000
53.52%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding LXRX
# of Institutions
141Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$103 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$29.6 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.38 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.09MShares$6.15 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $143M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...